{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:02:03Z","timestamp":1746331323413,"version":"3.40.4"},"reference-count":32,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,5,1]]},"DOI":"10.2169\/internalmedicine.4301-24","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T22:11:00Z","timestamp":1726611060000},"page":"1380-1387","source":"Crossref","is-referenced-by-count":0,"title":["Nocardiosis in a Patient with Nephrotic Syndrome Treated with Glucocorticoids and Tacrolimus"],"prefix":"10.2169","volume":"64","author":[{"given":"Kensei","family":"Taguchi","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Japan"},{"name":"Research Institute of Medical Mass Spectrometry, Kurume University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Mitsuishi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koki","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakuya","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Fukami","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Moutzouris DA, Herlitz L, Appel GB, et al. Renal biopsy in the very elderly. Clin J Am Soc Nephrol 4: 1073-1082, 2009.","DOI":"10.2215\/CJN.00990209"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Minero MV, Mar\u00edn M, Cercenado E, Rabad\u00e1n PM, Bouza E, Mu\u00f1oz P. Nocardiosis at the turn of the century. Medicine (Baltimore) 88: 250-261, 2009.","DOI":"10.1097\/MD.0b013e3181afa1c8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Haussaire D, Fournier PE, Djiguiba K, et al. Nocardiosis in the south of France over a 10-years period, 2004-2014. Int J Infect Dis 57: 13-20, 2017.","DOI":"10.1016\/j.ijid.2017.01.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Coussement J, Lebeaux D, van Delden C, et al. <i>Nocardia<\/i> infection in solid organ transplant recipients: a multicenter European case-control study. Clin Infect Dis 63: 338-345, 2016.","DOI":"10.1093\/cid\/ciw241"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takamatsu A, Yaguchi T, Tagashira Y, Watanabe A, Honda H; Japan Nocardia Study Group. Nocardiosis in Japan: a multicentric retrospective cohort study. Antimicrob Agents Chemother 66: e0189021, 2022.","DOI":"10.1128\/aac.01890-21"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mehta HH, Shamoo Y. Pathogenic <i>Nocardia<\/i>: a diverse genus of emerging pathogens or just poorly recognized? PLoS Pathog 16: e1008280, 2020.","DOI":"10.1371\/journal.ppat.1008280"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Weinberg ED. The influence of soil on infectious disease. Experientia 43: 81-87, 1987.","DOI":"10.1007\/BF01940358"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Margalit I, Muhsen K, Ari YB, et al. <i>Nocardia<\/i> colonization in contrast to nocardiosis: a comparison of patients&apos; clinical characteristics. Eur J Clin Microbiol Infect Dis 39: 759-763, 2020.","DOI":"10.1007\/s10096-019-03796-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Steinbrink J, Leavens J, Kauffman CA, Miceli MH. Manifestations and outcomes of nocardia infections: comparison of immunocompromised and nonimmunocompromised adult patients. Medicine (Baltimore) 97: e12436, 2018.","DOI":"10.1097\/MD.0000000000012436"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wang HL, Seo YH, LaSala PR, Tarrand JJ, Han XY. Nocardiosis in 132 patients with cancer: microbiological and clinical analyses. Am J Clin Pathol 142: 513-523, 2014.","DOI":"10.1309\/AJCPW84AFTUWMHYU"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Li S, Song XY, Zhao YY, et al. Clinical analysis of pulmonary nocardiosis in patients with autoimmune disease. Medicine (Baltimore) 94: e1561, 2015.","DOI":"10.1097\/MD.0000000000001561"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kawano Y, Zavidij O, Park J, et al. Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression. J Clin Invest 128: 2487-2499, 2018.","DOI":"10.1172\/JCI88169"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ Jr. Clinical and laboratory features of the <i>Nocardia<\/i> spp. based on current molecular taxonomy. Clin Microbiol Rev 19: 259-282, 2006.","DOI":"10.1128\/CMR.19.2.259-282.2006"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yildiz O, Doganay M. Actinomycoses and <i>Nocardia<\/i> pulmonary infections. Curr Opin Pulm Med 12: 228-234, 2006.","DOI":"10.1097\/01.mcp.0000219273.57933.48"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lerner PI. Nocardiosis. Clin Infect Dis 22: 891-903; quiz 904-quiz 905, 1996.","DOI":"10.1093\/clinids\/22.6.891"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother 41: 296-308, 2007.","DOI":"10.1345\/aph.1H307"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zhao P, Zhang X, Du P, Li G, Li L, Li Z. Susceptibility profiles of <i>Nocardia<\/i> spp. to antimicrobial and antituberculotic agents detected by a microplate Alamar Blue assay. Sci Rep 7: 43660, 2017.","DOI":"10.1038\/srep43660"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lodise TP, Fang E, Minassian SL, Prokocimer PG. Platelet profile in patients with acute bacterial skin and skin structure infections receiving tedizolid or linezolid: findings from the phase 3 ESTABLISH clinical trials. Antimicrob Agents Chemother 58: 7198-7204, 2014.","DOI":"10.1128\/AAC.03509-14"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Attassi K, Hershberger E, Alam R, Zervos MJ. Thrombocytopenia associated with linezolid therapy. Clin Infect Dis 34: 695-698, 2002.","DOI":"10.1086\/338403"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hanai Y, Matsuo K, Ogawa M, et al. A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemia. J Infect Chemother 22: 536-542, 2016.","DOI":"10.1016\/j.jiac.2016.05.003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ogi M, Yokoyama H, Tomosugi N, et al. Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome. Am J Kidney Dis 24: 427-436, 1994.","DOI":"10.1016\/S0272-6386(12)80899-7"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Beaman BL, Beaman L. <i>Nocardia<\/i> species: host-parasite relationships. Clin Microbiol Rev 7: 213-264, 1994.","DOI":"10.1128\/CMR.7.2.213"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Deem RL, Doughty FA, Beaman BL. Immunologically specific direct T lymphocyte-mediated killing of <i>Nocardia asteroides<\/i>. J Immunol 130: 2401-2406, 1983.","DOI":"10.4049\/jimmunol.130.5.2401"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Tam S, Maksaereekul S, Hyde DM, Godinez I, Beaman BL. IL-17 and \u03b3\u03b4 T-lymphocytes play a critical role in innate immunity against <i>Nocardia asteroides<\/i> GUH-2. Microbes Infect 14: 1133-1143, 2012.","DOI":"10.1016\/j.micinf.2012.05.008"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Anagnostou T, Arvanitis M, Kourkoumpetis TK, Desalermos A, Carneiro HA, Mylonakis E. Nocardiosis of the central nervous system: experience from a general hospital and review of 84 cases from the literature. Medicine (Baltimore) 93: 19-32, 2014.","DOI":"10.1097\/MD.0000000000000012"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol 17: 233-247, 2017.","DOI":"10.1038\/nri.2017.1"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Vafadari R, Kraaijeveld R, Weimar W, Baan CC. Tacrolimus inhibits NF-\u03baB activation in peripheral human T cells. PLoS One 8: e60784, 2013.","DOI":"10.1371\/journal.pone.0060784"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Speakman EA, Dambuza IM, Salazar F, Brown GD. T Cell antifungal immunity and the role of C-type lectin receptors. Trends Immunol 41: 61-76, 2020.","DOI":"10.1016\/j.it.2019.11.007"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Herbst S, Shah A, Moya MM, et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to <i>Aspergillus fumigatus<\/i>. EMBO Mol Med 7: 240-258, 2015.","DOI":"10.15252\/emmm.201404556"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Yokoyama H, Sugiyama H, Narita I, et al. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 19: 496-505, 2015.","DOI":"10.1007\/s10157-014-1022-x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Han S, Georgiev P, Ringel AE, Sharpe AH, Haigis MC. Age-associated remodeling of T cell immunity and metabolism. Cell Metab 35: 36-55, 2023.","DOI":"10.1016\/j.cmet.2022.11.005"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Yamaguchi M, Ando M, Yamamoto R, et al. Patient age and the prognosis of idiopathic membranous nephropathy. PLoS One 9: e110376, 2014.","DOI":"10.1371\/journal.pone.0110376"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/9\/64_4301-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:01:07Z","timestamp":1746244867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/9\/64_4301-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4301-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"article-number":"4301-24"}}